PAPER Asp I, Cawley-Bennett AT, Frascino JC, Golshan S, Bondi MW, Smith CN
SEARCH RESULTS
330712 RESULTS
PAPER Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Brockmann K, Svoboda H, Trundell D, Monnet A, Doody R, Fontoura P, Kerchner GA, Brundin P, Nikolcheva T, Bonni A, PASADENA Investigators, Prasinezumab Study Group
Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
Nat Med. 2024 Apr 15; PubMed: 38622249PAPER Rosano C, Karikari TK, Cvejkus R, Bellaver B, Ferreira PC, Zmuda J, Wheeler V, Pascoal TA, Miljkovic I
Sex differences in Alzheimer's disease blood biomarkers in a Caribbean population of African ancestry: The Tobago Health Study.
Alzheimers Dement (N Y). 2024;10(2):e12460. Epub 2024 Apr 12 PubMed: 38617114PAPER Villain N, Michalon R
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuries.
Eur J Neurol. 2024 Apr 15;:e16302. PubMed: 38618742PAPER Sekar A, Panouillères MT, Kaski D
Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases- Current Insights.
Eye Brain. 2024;16:3-16. Epub 2024 Apr 9 PubMed: 38617403PAPER Smith B, Ownby RL
Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management.
Cureus. 2024 Mar;16(3):e56105. Epub 2024 Mar 13 PubMed: 38618323PAPER Azzini E, Peña-Corona SI, Hernández-Parra H, Chandran D, Saleena LA, Sawikr Y, Peluso I, Dhumal S, Kumar M, Leyva-Gómez G, Martorell M, Sharifi-Rad J, Calina D
Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
Phytother Res. 2024 Apr 14; PubMed: 38616356PAPER Wei B, Xu Y, Du Y, Zhou J, Zhong F, Wu C, Lou Y
Feasibility of Using Magnetic Resonance Spectroscopy Test Biomarkers to Diagnose Alzheimer's Disease: Systematic Evaluation and Meta-Analysis.
Actas Esp Psiquiatr. 2024 Apr;52(2):161-171. PubMed: 38622011PAPER Tu K, Zhou W, Kong S
Integrating Multi-omics Data for Alzheimer's Disease to Explore Its Biomarkers Via the Hypergraph-Regularized Joint Deep Semi-Non-Negative Matrix Factorization Algorithm.
J Mol Neurosci. 2024 Apr 15;74(2):43. PubMed: 38619646PAPER Iba M, Kwon S, Kim C, Szabo M, Horan-Portelance L, Lopez-Ocasio M, Dagur P, Overk C, Rissman RA, Masliah E
Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease.
J Neuroinflammation. 2024 Apr 15;21(1):93. PubMed: 38622654PAPER McGrath A, Pai H, Clack A
The rapid progression of Creutzfeldt-Jakob disease with concomitant COVID-19 infection: a case report.
Clin Med (Lond). 2023 Nov;23 Suppl 6:21-22. PubMed: 38614710PAPER Ren Z, Nie L, Du Y, Liu J
Intertwined depressive and cognitive trajectories and the risk of dementia and death in older adults: a competing risk analysis.
Gen Psychiatr. 2024;37(2):e101156. Epub 2024 Apr 9 PubMed: 38616970Yoonho Cho
St. Louis, United States
Elizabeth Fisher
NovartisCambridge, United States
Markus Zweckstetter on Could Sumoylation Take Down Tangles?
COMMENT This highly interesting study supports an important role of sumoylation as a post-translational modification that solubilizes aggregation prone proteins. The study focuses on SUMO2, and it will be interesting to see how modification by SUMO2 compares to m
Current Filters
- Date Range : All x